| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acquired immune deficiency syndrome polypeptide obtained by cloning etc. and used in diagnosis and vaccines against AIDS virus HTLV-III virus
|
|
|
1987
|
5 |
1 |
p. 71-
1 p.
|
article
|
| 2 |
adr-type hepatitis B virus surface antigen for vaccine production obtained by culture of human hepatoma cell strain huGK-14
|
|
|
1987
|
5 |
1 |
p. 72-
1 p.
|
article
|
| 3 |
Age and dose interval as factors in agglutinin formation to pertussis vaccine
|
Wilkins, Jeanette
|
|
1987
|
5 |
1 |
p. 49-54
6 p.
|
article
|
| 4 |
An integrated molecular and immunological approach towards a meningococcal group B vaccine
|
Lifely, M.R.
|
|
1987
|
5 |
1 |
p. 11-26
16 p.
|
article
|
| 5 |
Antigen specific to non-A, non-B hepatitis virus: application for vaccine production
|
|
|
1987
|
5 |
1 |
p. 72-
1 p.
|
article
|
| 6 |
Babesia parasite antigen useful in vaccine and diagnostic reagent
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 7 |
Calendar
|
|
|
1987
|
5 |
1 |
p. 80-
1 p.
|
article
|
| 8 |
Compositions for protecting mammals against influenza virus: vaccine preparation containing T-cell inducing nucleoprotein
|
|
|
1987
|
5 |
1 |
p. 73-
1 p.
|
article
|
| 9 |
Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines
|
Pay, T.W.F.
|
|
1987
|
5 |
1 |
p. 60-64
5 p.
|
article
|
| 10 |
Cultivating Pseudomonas aeruginosa strains which produce H-type antigens using fully synthetic nutrient medium free from antigens and proteins; useful for vaccine production
|
|
|
1987
|
5 |
1 |
p. 71-
1 p.
|
article
|
| 11 |
Editorial Board
|
|
|
1987
|
5 |
1 |
p. IFC-
1 p.
|
article
|
| 12 |
Immunizing fowl against infectious bronchitis: vaccine production by inactivation of bird infectious-bronchitis virus VLO 10110/AVI/9
|
|
|
1987
|
5 |
1 |
p. 71-
1 p.
|
article
|
| 13 |
Influenza virus inactivated vaccine for pig: virus culture in embryonated egg allantoin and preparation
|
|
|
1987
|
5 |
1 |
p. 72-
1 p.
|
article
|
| 14 |
Injectable Bordetella bronchiseptica vaccine for preventing atrophic rhinitis and turbinate atrophy in pigs
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 15 |
Local response in rat to liposome-associated Streptococcus mutans polysaccharide-protein conjugate
|
Bruyere, T.
|
|
1987
|
5 |
1 |
p. 39-42
4 p.
|
article
|
| 16 |
New Bordetella pertussis toxin clone construction and characterization: Gene cloning and expression in Escherichia coli; production of pure antigen peptides for use in vaccines against whooping cough
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 17 |
New canine parvo virus strain 154 and use in vaccine effective in young animals in the presence of maternal antibodies
|
|
|
1987
|
5 |
1 |
p. 72-
1 p.
|
article
|
| 18 |
New immunoreactive HTLV-III virus polypeptide expressed by transformed cells and monoclonal antibodies useful for AIDS diagnosis and vaccine
|
|
|
1987
|
5 |
1 |
p. 71-
1 p.
|
article
|
| 19 |
Novel immunostimulating glycoproteins
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 20 |
O-Polysaccharide-protein conjugates induce high levels of specific antibodies to Pseudomonas aeruginosa immunotype 3 lipopolysaccharide
|
van de Wiel, Paul A.
|
|
1987
|
5 |
1 |
p. 33-38
6 p.
|
article
|
| 21 |
Oral vaccine for prophylaxis of periodontitis using the whole cell pilus or extract of Bacterioides gingivalis etc.
|
|
|
1987
|
5 |
1 |
p. 72-
1 p.
|
article
|
| 22 |
987P Fimbriae-producing microorganism used for vaccinating pigs to prevent diarrhoea caused by Escherichia coli
|
|
|
1987
|
5 |
1 |
p. 73-74
2 p.
|
article
|
| 23 |
Plasmid containing vaccinia virus haemagglutinin gene for vaccine production
|
|
|
1987
|
5 |
1 |
p. 73-
1 p.
|
article
|
| 24 |
Preparation of foot-and-mouth disease virus in tissue culture: inactivated vaccine for pig
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 25 |
Production of conformation-independent antigens by denaturing the conformation-dependent antigenic determinant for analysis and vaccine against hepatitis B virus
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 26 |
Production of live vaccines e.g. Salmonella from pathogen mutants with resistance to 1 or 2 antibacterial agents
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 27 |
Production of Marek's disease vaccine by freeze drying fowl embryo cells with turkey herpes virus
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 28 |
Production of polypeptide for vaccine against malaria by cultivation of Escherichia coli transformed with vector coding for repeat unit circumsporozoite protein of Plasmodium falciparum
|
|
|
1987
|
5 |
1 |
p. 72-
1 p.
|
article
|
| 29 |
Prospects for the prevention of meningococcal disease: special reference to group B
|
Frasch, Carl E.
|
|
1987
|
5 |
1 |
p. 3-4
2 p.
|
article
|
| 30 |
Purified non-A, non-B hepatitis virus antigen useful in vaccine
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 31 |
Quality assurance and testing in vaccine production for determination of surface antigens of e.g. Escherichia coli
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 32 |
Recent developments in the design and construction of facilities for the production of human injectables
|
Smith, David T.
|
|
1987
|
5 |
1 |
p. 5-10
6 p.
|
article
|
| 33 |
Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain
|
Morita, M.
|
|
1987
|
5 |
1 |
p. 65-70
6 p.
|
article
|
| 34 |
Role of bovine mammillitis virus towards preparation of an alternative vaccine against herpes simplex virus infections of human subjects
|
Skinner, G.R.B.
|
|
1987
|
5 |
1 |
p. 55-59
5 p.
|
article
|
| 35 |
Safe vaccine for hepatitis containing polymerized serum albumin
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 36 |
Simultaneous vaccination by three living attenuated strains of Brucella, Salmonella and Chlamydia in mice
|
Plommet, Michel
|
|
1987
|
5 |
1 |
p. 27-32
6 p.
|
article
|
| 37 |
Synthetic heat-stable enterotoxin polypeptide of E. coli and multimers thereof
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 38 |
Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 39 |
Synthetic polypeptide fragments
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 40 |
Trivalent influenza vaccine in patients on haemodialysis: Impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components
|
Beyer, W.E.P.
|
|
1987
|
5 |
1 |
p. 43-48
6 p.
|
article
|
| 41 |
Two-step rabies vaccine preparation by culturing the virus on BHK cells containing calf serum followed by repeated freeze thawing, centrifugation and lyophilization
|
|
|
1987
|
5 |
1 |
p. 71-
1 p.
|
article
|
| 42 |
Vaccine against adenovirus infections in cattle: preparation by cultivation of adenovirus on young cattle kidney cell culture
|
|
|
1987
|
5 |
1 |
p. 73-
1 p.
|
article
|
| 43 |
Vaccine against coli-bacillar entero-toxicosis: preparation from Escherichia coli
|
|
|
1987
|
5 |
1 |
p. 73-
1 p.
|
article
|
| 44 |
Vaccine against contagious sheep ecthyma prepared by growing ecthyma virus on calf renal tissue
|
|
|
1987
|
5 |
1 |
p. 73-
1 p.
|
article
|
| 45 |
Vaccine against Neisseria meningitidis group B serotype 2 invasive disease
|
|
|
1987
|
5 |
1 |
p. 74-
1 p.
|
article
|
| 46 |
Vaccine against Neisseria meningitidis group B serotype 2 invasive disease: single type 2 antigen adjuvanted with aluminium hydroxide
|
|
|
1987
|
5 |
1 |
p. 73-
1 p.
|
article
|
| 47 |
Vaccine for use in cases of sheep foot-rot comprising at least one protease of Bacteroides nodosus
|
|
|
1987
|
5 |
1 |
p. 72-73
2 p.
|
article
|
| 48 |
Vaccine for varicella-zoster virus produced by genetic engineering techniques using a DNA segment encoding at least a part of the virus glycoprotein C
|
|
|
1987
|
5 |
1 |
p. 71-
1 p.
|
article
|
| 49 |
Workshop on vaccine production
|
|
|
1987
|
5 |
1 |
p. 75-78
4 p.
|
article
|
Journal description